Literature DB >> 16601534

A behavior change intervention for women in cardiac rehabilitation.

Theresa M Beckie1.   

Abstract

There is undeniable evidence for physical and psychosocial benefits of cardiac rehabilitation programs for individuals suffering from coronary heart disease. Yet, fewer women than men are referred to, begin, or complete cardiac rehabilitation programs. The numerous logistical, economic, and motivational barriers to healthy behavior change place women at risk for subsequent CHD events. To close this gender gap and improve outcomes, novel, efficacious, and individualized rehabilitative approaches for women with coronary heart disease are needed. The purpose of this article is to describe a theory-driven behavioral intervention designed exclusively for women with coronary heart disease. The 12-week intervention is being tested in a randomized controlled trial involving women referred to a cardiac rehabilitation program. The tenets of the Transtheoretical Model of behavior change and motivational interviewing guided the development and implementation of the stage-matched, individualized intervention to promote healthy behavior change for women with coronary heart disease. The ongoing trial will examine the efficacy of the intervention on physiological and psychosocial outcomes.

Entities:  

Mesh:

Year:  2006        PMID: 16601534     DOI: 10.1097/00005082-200603000-00013

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  17 in total

1.  The effects of a cardiac rehabilitation program tailored for women on their perceptions of health: a randomized clinical trial.

Authors:  Theresa M Beckie; Jason W Beckstead
Journal:  J Cardiopulm Rehabil Prev       Date:  2011 Jan-Feb       Impact factor: 2.081

2.  The relationship between polymorphisms on chromosome 9p21 and age of onset of coronary heart disease in black and white women.

Authors:  Theresa M Beckie; Maureen W Groër; Jason W Beckstead
Journal:  Genet Test Mol Biomarkers       Date:  2011-03-04

3.  The association between variants on chromosome 9p21 and inflammatory biomarkers in ethnically diverse women with coronary heart disease: a pilot study.

Authors:  Theresa M Beckie; Jason W Beckstead; Maureen W Groer
Journal:  Biol Res Nurs       Date:  2011-07       Impact factor: 2.522

4.  Predicting cardiac rehabilitation attendance in a gender-tailored randomized clinical trial.

Authors:  Theresa M Beckie; Jason W Beckstead
Journal:  J Cardiopulm Rehabil Prev       Date:  2010 May-Jun       Impact factor: 2.081

5.  The effects of a tailored cardiac rehabilitation program on depressive symptoms in women: A randomized clinical trial.

Authors:  Theresa M Beckie; Jason W Beckstead; Douglas D Schocken; Mary E Evans; Gerald F Fletcher
Journal:  Int J Nurs Stud       Date:  2010-07-07       Impact factor: 5.837

Review 6.  Promoting patient uptake and adherence in cardiac rehabilitation.

Authors:  Philippa Davies; Fiona Taylor; Andrew Beswick; Frances Wise; Tiffany Moxham; Karen Rees; Shah Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2010-07-07

7.  The effects of a cardiac rehabilitation program tailored for women on global quality of life: a randomized clinical trial.

Authors:  Theresa M Beckie; Jason W Beckstead
Journal:  J Womens Health (Larchmt)       Date:  2010-09-16       Impact factor: 2.681

8.  Physiological and exercise capacity improvements in women completing cardiac rehabilitation.

Authors:  Theresa M Beckie; Jason W Beckstead; Kevin Kip; Gerald Fletcher
Journal:  J Cardiopulm Rehabil Prev       Date:  2013 Jan-Feb       Impact factor: 2.081

9.  Improvements in heart rate recovery among women after cardiac rehabilitation completion.

Authors:  Theresa M Beckie; Jason W Beckstead; Kevin E Kip; Gerald Fletcher
Journal:  J Cardiovasc Nurs       Date:  2014 Jan-Feb       Impact factor: 2.083

10.  The influence of cardiac rehabilitation on inflammation and metabolic syndrome in women with coronary heart disease.

Authors:  Theresa M Beckie; Jason W Beckstead; Maureen W Groer
Journal:  J Cardiovasc Nurs       Date:  2010 Jan-Feb       Impact factor: 2.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.